<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04250476644475</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN51-AKZ-MC-S01</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:53.032Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645106</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN56-AKZ-PI-XS1</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:53.017Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645120</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN56-AKZ-PI-S01</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:53.002Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645144</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN56-AKZ-PI-M01</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.983Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645168</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>SMART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN51-AKZ-IB-XL1</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.970Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645182</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>SMART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN51-AKZ-IB-LL1</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.954Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645205</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>SMART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN51-AKZ-IB-M01</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.942Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645229</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>SMART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN51-AKZ-IB-S01</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.926Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645243</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>SMART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN51-AKZ-IB-XS1</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.909Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645267</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>ART|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBN51-AKZ-BK-XL1</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.894Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645281</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>PRIME|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBY53-AKZ-TL-LL1</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.881Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645304</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>PRIME|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBY53-AKZ-TL-M01</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.866Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645328</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>PRIME|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBY53-AKZ-TL-S01</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.852Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645342</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>PRIME|ONE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>GLOBY53-AKZ-TL-XS1</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.841Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645366</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33542</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.828Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645380</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33544</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.812Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645403</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33546</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.796Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645427</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33548</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.783Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645441</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33542-V</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.762Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250476645465</udiDi>
    <basicUdiDi>42504766GLOUP</basicUdiDi>
    <tradeName>STARLINE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Akzenta International SA</manufacturerName>
    <manufacturerSrn>CH-MF-000036434</manufacturerSrn>
    <authorisedRepresentativeName>IQX GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000016713</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE33544-V</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-21T05:15:52.744Z</lastUpdated>
  </row>
</eudamedExport>